Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABOUND 70+: Nab-paclitaxel + Carboplatin in Elderly NSCLC
NCT02151149Phase 4Completed
- Sponsor
- Celgene Corporation
- Start
- Jun 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nab-paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Celgene Corporation. Started Jun 2014; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02151149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151149.